A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

More Information

Trial Status
Accepting patients
Trial Phase
Phase 1
Enrollment
186 patients (estimated)
Sponsors
Orca Biosystems, Inc.
Tags
Allogeneic Stem Cell Transplant
Trial Type
Supportive
Last Update
2 months ago
SparkCures ID
1669
NCT Identifier
NCT03802695

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.